eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase III trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy in patients with high risk, early stage endometrial carcinoma

eagle-i ID


Resource Type

  1. Interventional study


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
    Radiation therapy
  4. Intervention
  5. Intervention
  6. Resource Description
    This randomized phase III trial is studying pelvic radiation therapy to see how well it works compared with vaginal implant radiation therapy, paclitaxel, and carboplatin in treating patients with high-risk stage I or stage II endometrial cancer.
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Berenberg, Jeffrey
  9. Topic
    endometrial cancer
  10. Study Population
    Females at least 18 years old with no more than 12 weeks since undergoing surgery to remove the uterus, ovaries, and fallopian tubes, no stage III, stage IV, or recurrent cancer, no sarcoma, carcinosarcoma, or leiomyosarcoma of the uterus, no previous chemotherapy, radiation therapy, hormone therapy, or biological therapy for endometrial cancer, and no previous chemotherapy or radiation therapy for any other cancer.
  11. Website(s)
  12. Website(s)
  13. Funded by
    Gynecologic Oncology Group
  14. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016